News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Ivax may be ripe for merger - report (Reuters Securities)...Ivax, which specializes in marketing generic versions of existing drugs, is also testing a promising immunotoxin drug for brain cancer, the report said....- Jun 14 8:58 PM ET


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)



Website: http://biz.yahoo.com/rf/010614/n14583042.html

Posted on: 06/14/2001

"Yahoo - Ivax may be ripe for merger - report"
Yahoo! Finance Finance Home - Yahoo! - Help
Reuters

[ Latest Headlines | Market Overview | News Alerts ]


Related Quotes
IVX
39.04
+1.54
delayed 20 mins - disclaimer
Thursday June 14, 8:58 pm Eastern Time

Ivax may be ripe for merger - report

NEW YORK, June 14 (Reuters) - Drug maker Ivax Corp. (AMEX:IVX - news) may be ripe for a takeover by drug giants AstraZeneca Plc (quote from Yahoo! UK & Ireland: AZN.L) or GlaxoSmithKline Plc (quote from Yahoo! UK & Ireland: GSK.L), according to a report in Business Week magazine.

Ivax, which specializes in marketing generic versions of existing drugs, is also testing a promising immunotoxin drug for brain cancer, the report said.

Ivax said on Wednesday it expects second quarter earnings to exceed analysts' expectations, which it pegged at 25 cents per share, as tracked by research firm Thomson Financial/First Call.

Email this story - Most-emailed articles - Most-viewed articles


More Quotes and News:Ivax Corp (AMEX:IVX - news)
Related News Categories: biotech, health, medical/pharmaceutical, US Market News

Help


Copyright © 2001 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Copyright © 2001 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Questions or Comments?
"


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740